PMV Pharmaceuticals, Inc.
PMVP · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $55,131 | $56,628 | $77,877 |
| - Cash | $36,337 | $44,127 | $51,341 | $40,876 |
| + Debt | $541 | $1,020 | $1,106 | $1,190 |
| Enterprise Value | – | $12,024 | $6,393 | $38,191 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$32 | -$32 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$21,033 | -$21,173 | -$21,527 | -$25,129 |
| % Margin | – | – | – | – |
| Net Income | -$21,059 | -$21,210 | -$17,436 | -$23,000 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.397 | -0.41 | -0.34 | 0.37 |
| % Growth | 3.1% | -20.6% | -191.9% | – |
| Operating Cash Flow | -$19,820 | -$18,302 | -$18,266 | -$16,661 |
| Capital Expenditures | $1 | -$11 | -$4 | -$56 |
| Free Cash Flow | -$19,819 | -$18,313 | -$18,270 | -$16,717 |